PLZF and its fusion proteins are pomalidomide-dependent CRBN neosubstrates
Shimizu et al. identify PLZF/ZBTB16 and its fusion proteins as pomalidomide-dependent neosubstrates of the cereblon E3 ligase. The authors also report that pomalidomide induces their degradation and thereby exerts its anti-cancer effect in leukemic cells expressing the fusion proteins.
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/8e042573d7f949a6bd3a74bcd451d1ff |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|